Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists

AIMS: The objective of this study was to investigate whether baseline receptor activator for nuclear factor kappaB ligand (RANKL) and osteoprotegerin (OPG) serum (s) levels can predict the therapeutic response to TNF antagonists (a‐TNF). METHODS: We studied 75 rheumatoid arthritis patients (81% fema...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: González‐Alvaro, Isidoro, Ortiz, Ana M, Tomero, Eva G, Balsa, Alejandro, Orte, Javier, Laffon, Armando, García‐Vicuña, Rosario
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Concise Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095335/
https://ncbi.nlm.nih.gov/pubmed/17666448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.071910
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados